Straits Times Index
3,204.82 +2.01 (+0.06%) S&P 500
4,320.06 -9.94 (-0.23%) Dow
33,963.84 -106.56 (-0.31%) Nasdaq
13,211.81 -12.19 (-0.09%) Bitcoin USD
26,170.16 -406.85 (-1.53%) CMC Crypto 200
559.14 -8.91 (-1.57%)
LLY Jan 2025 320.000 call
| Previous close | 218.00 |
| Open | 210.45 |
| Bid | 274.25 |
| Ask | 278.00 |
| Strike | 320.00 |
| Expiry date | 2025-01-17 |
| Day's range | 210.45 - 222.65 |
| Contract range | N/A |
| Volume | |
| Open interest | 40 |
Motley Fool3 Magnificent Growth Stocks to Buy Right Now
Three Fool.com contributors believe they've identified truly magnificent growth stocks to buy right now. Here's why they chose AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (AstraZeneca): What makes AstraZeneca a magnificent long-term investment is how broad the business is and the potential it has to generate long-term gains.
- Investing.com
Global Weight-Loss Drug Market Projected to Hit $100 Billion by 2035
In a recent forecast, BMO Capital Markets has predicted the global market for innovative weight-loss drugs, such as Novo Nordisk (NYSE:NVO) A/S's Ozempic and Wegovy, to reach $100 billion by 2035. This projection follows an increase in patient recognition of the efficacy of these medications.
Motley FoolAre Wall Street Analysts Wrong About Eli Lilly Stock?
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.
